Genpact (G) Price Target Lowered to $37.00 at JPMorgan Chase & Co.

Genpact (NYSE:G) had its price objective reduced by JPMorgan Chase & Co. from $38.00 to $37.00 in a note issued to investors on Wednesday. The brokerage currently has a “neutral” rating on the business services provider’s stock. JPMorgan Chase & Co.’s target price indicates a potential upside of 20.01% from the company’s previous close.

A number of other analysts also recently weighed in on the company. Citigroup decreased their price target on Genpact from $39.00 to $37.50 and set a “buy” rating on the stock in a research note on Tuesday. BMO Capital Markets lifted their price target on Genpact to $35.00 and gave the company a “market perform” rating in a research note on Tuesday. Cantor Fitzgerald restated a “buy” rating and issued a $36.00 price target on shares of Genpact in a research note on Tuesday. Zacks Investment Research downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th. Finally, Robert W. Baird restated a “buy” rating and issued a $38.00 price target on shares of Genpact in a research note on Friday, November 10th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Genpact presently has a consensus rating of “Buy” and an average price target of $34.65.

Shares of Genpact (NYSE:G) traded up $0.51 during mid-day trading on Wednesday, hitting $30.83. The company’s stock had a trading volume of 1,015,551 shares, compared to its average volume of 861,725. Genpact has a one year low of $23.34 and a one year high of $34.79. The stock has a market cap of $6,235.27, a P/E ratio of 23.01, a P/E/G ratio of 2.01 and a beta of 0.57. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77.

Genpact (NYSE:G) last announced its earnings results on Monday, February 12th. The business services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.02. Genpact had a return on equity of 23.53% and a net margin of 9.61%. The company had revenue of $734.41 million for the quarter, compared to the consensus estimate of $723.55 million. During the same period last year, the business posted $0.43 EPS. The company’s revenue was up 7.7% on a year-over-year basis. research analysts expect that Genpact will post 1.61 EPS for the current year.

In other news, insider Private Ltd Gic sold 1,499,806 shares of Genpact stock in a transaction on Monday, November 20th. The stock was sold at an average price of $30.26, for a total value of $45,384,129.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Arvinder Singh sold 22,690 shares of Genpact stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total value of $770,325.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,660,470 shares of company stock valued at $50,598,982. Insiders own 1.41% of the company’s stock.

Several large investors have recently made changes to their positions in the company. The Manufacturers Life Insurance Company grew its position in Genpact by 7.5% during the second quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after acquiring an additional 455 shares during the period. Ameriprise Financial Inc. grew its position in Genpact by 3.1% during the second quarter. Ameriprise Financial Inc. now owns 30,196 shares of the business services provider’s stock valued at $840,000 after acquiring an additional 907 shares during the period. Sit Investment Associates Inc. grew its position in Genpact by 4.5% during the fourth quarter. Sit Investment Associates Inc. now owns 37,100 shares of the business services provider’s stock valued at $1,178,000 after acquiring an additional 1,590 shares during the period. FDx Advisors Inc. grew its position in Genpact by 2.9% during the third quarter. FDx Advisors Inc. now owns 61,488 shares of the business services provider’s stock valued at $1,768,000 after acquiring an additional 1,713 shares during the period. Finally, Commerzbank Aktiengesellschaft FI grew its position in Genpact by 12.4% during the third quarter. Commerzbank Aktiengesellschaft FI now owns 16,466 shares of the business services provider’s stock valued at $473,000 after acquiring an additional 1,816 shares during the period. 92.00% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Genpact (G) Price Target Lowered to $37.00 at JPMorgan Chase & Co.” was posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/14/genpact-g-price-target-lowered-to-37-00-at-jpmorgan-chase-co.html.

Genpact Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Analyst Recommendations for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply